Ken is a theoretical physicist and one of his research interests is pharmacokinetics. Pharmacokinetics describes the motion of a drug in the human body and its interaction with the human body. The human body is highly heterogeneous and hence the transport and chemical reaction processes occurring within the human body are highly anomalous. The primary focus of the research is to develop physiologically accurate theoretical models of the drug transport and interaction with the human body. The research focuses on the administration of drugs but has applications in all stages of drug discovery, development, and administration. This work is being done in collaboration with researchers at the Cross Cancer Institute in Edmonton, Alberta.